The Phaserl


Vitamin D inhibits prostate cancer by activating inflammation-regulating gene, study suggests

by David Gutierrez, Natural News:

Vitamin D may reduce prostate cancer risk by acting on a gene that lowers inflammation, according to a study conducted by researchers from the University of Colorado Cancer Center and published in the journal Prostate.

Back in 1990, scientists first suggested that vitamin D might be the common variable linking a number of known prostate cancer risk factors, including older age (associated with reduced vitamin D synthesis), living at a northern latitude (where people are more likely to be vitamin D-deficient due to lower levels of the sunlight that stimulates synthesis of the vitamin) and African descent (because darker skin leads to reduced vitamin D synthesis). In addition, studies had shown that prostate cancers diagnosed in the summer or autumn, when vitamin D levels in the body tend to be highest, were less deadly than those diagnosed in the winter or spring.

Read More @

Help us spread the ANTIDOTE to corporate propaganda.

Please follow SGT Report on Twitter & help share the message.

Leave a Reply

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>